Document ID: chunk:federal_register_of_legislation:F2025L00053:clause:1_6
Version: federal_register_of_legislation:F2025L00053
Segment Type: clause
Provision Reference: sch 1 cl 6
Character Range: 8287–8912

6  Schedule 1 (table)
After:
Pioglitazone  Tablet 45 mg (as hydrochloride)  Oral  ARX-PIOGLITAZONE  4 months stock by reference to usual demand of both APOTEX-Pioglitazone and ARX-PIOGLITAZONE added together

insert:
Piroxicam                                      Dispersible tablet 20 mg           Oral                    Feldene-D  between 1 February 2025 and 31 March 2025—0 months stock by reference to usual demand
Polyethylene glycol 400 with propylene glycol  Eye drops 4 mg-3 mg per mL, 15 mL  Application to the Eye  Optix      between 1 February 2025 and 30 April 2025—0 months stock by reference to usual demand